JOHN FOREYT to Medroxyprogesterone Acetate
This is a "connection" page, showing publications JOHN FOREYT has written about Medroxyprogesterone Acetate.
Connection Strength
0.465
-
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010 Oct 20; 304(15):1684-92.
Score: 0.171
-
Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009 Feb 05; 360(6):573-87.
Score: 0.152
-
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008 Mar 05; 299(9):1036-45.
Score: 0.143